Response Biomedical develops, manufactures and markets rapid on-site diagnostic tests.
Acquired by OrbiMed
Response Biomedical Corp. ("Response") (TSX: RBM, OTCBB: RPBIF) develops, manufactures and markets rapid on-site diagnostic tests at its world class manufacturing facility in Vancouver, Canada, for use on the RAMP® Platform. The RAMP® Platform is sold worldwide and includes a variety of testing applications in the clinical, infectious
disease, biodefense and environmental arenas. The RAMP® Platform provides laboratory quality results with the speed, precision and accuracy that many hospitals expect of their central lab systems. It is ideally suited for both point of care testing and laboratory use.